Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-28 @ 2:05 PM
Study NCT ID:
NCT00434967
Status:
COMPLETED
Last Update Posted:
2010-12-16
First Post:
2007-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-13
First Submit QC Date:
None
Study First Post Date:
2007-02-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-01-09
Results First Submit QC Date:
None
Results First Post Date:
2009-06-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-11-30
Last Update Post Date:
2010-12-16
Last Update Post Date Type:
ESTIMATED